These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Albendazole therapy for neurocysticercosis. Sanchetee PC; Venkataraman S; Dhamija RM; Roy AK J Assoc Physicians India; 1994 Feb; 42(2):116-7. PubMed ID: 7860469 [TBL] [Abstract][Full Text] [Related]
45. [Cysticercosis of the brain in the USA]. Gasecki AP; Pfeiffer RF Neurol Neurochir Pol; 1990; 24(1-2):111-2. PubMed ID: 2132046 [No Abstract] [Full Text] [Related]
46. Case Report: Cysticercosis: Sonographic Diagnosis of a Treatable Cause of Epilepsy and Skin Nodules. Heller T; Wallrauch C; Kaminstein D; Phiri S Am J Trop Med Hyg; 2017 Dec; 97(6):1827-1829. PubMed ID: 29016298 [TBL] [Abstract][Full Text] [Related]
47. Intramedullary spinal cysticercosis: response to albendazole: case reports and review of literature. Garg RK; Nag D Spinal Cord; 1998 Jan; 36(1):67-70. PubMed ID: 9471142 [TBL] [Abstract][Full Text] [Related]
48. Neurocysticercosis. Suri W; Kalra V Med J Aust; 1994 Feb; 160(4):231-2. PubMed ID: 8309399 [No Abstract] [Full Text] [Related]
51. Advances in treatment of neurocysticercosis. Agarwal AK; Dudeja RK; Chandra S J Assoc Physicians India; 1994 Jan; 42(1):88. PubMed ID: 7836272 [No Abstract] [Full Text] [Related]
52. Neurocysticercosis: clinical and therapeutic considerations. Review of Italian literature. Bussone G; La Mantia L; Frediani F; Lamperti E; Salmaggi A; Campi A; Sinatra MG; Boiardi A Ital J Neurol Sci; 1986 Oct; 7(5):525-9. PubMed ID: 3804707 [TBL] [Abstract][Full Text] [Related]
53. Cerebral cysticercosis manifesting as hydrocephalus--case report. Oka Y; Fukui K; Shoda D; Abe T; Kumon Y; Sakaki S; Torii M Neurol Med Chir (Tokyo); 1996 Sep; 36(9):654-8. PubMed ID: 8913084 [TBL] [Abstract][Full Text] [Related]
54. Treatment of neurocysticercosis. Joubert J; Jenni WK S Afr Med J; 1990 Jan; 77(1):27-30. PubMed ID: 2294609 [TBL] [Abstract][Full Text] [Related]
55. Subarachnoid neurocysticercosis with occlusion of the major intracranial arteries: case report. Levy AS; Lillehei KO; Rubinstein D; Stears JC Neurosurgery; 1995 Jan; 36(1):183-8; discussion 188. PubMed ID: 7708157 [TBL] [Abstract][Full Text] [Related]
56. [Neurocysticercosis: a rare cause of convulsive crises]. Domenici R; Matteucci L; Meossi C; Stefani G; Frugoli G Pediatr Med Chir; 1995; 17(6):577-81. PubMed ID: 8668597 [TBL] [Abstract][Full Text] [Related]
57. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel. Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213 [TBL] [Abstract][Full Text] [Related]
58. MR observations on the effects of praziquantel in neurocysticercosis. Jena A; Sanchetee PC; Tripathi R; Jain RK; Gupta AK; Sapra ML Magn Reson Imaging; 1992; 10(1):77-80. PubMed ID: 1545685 [TBL] [Abstract][Full Text] [Related]
59. Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis. Santos IC; Kobayashi E; Cardoso TM; Guerreiro CA; Cendes F Arq Neuropsiquiatr; 2000 Dec; 58(4):1014-20. PubMed ID: 11105066 [TBL] [Abstract][Full Text] [Related]
60. [Cerebral cysticercosis: imaging, serology, treatment and evolution. Apropos of 2 cases]. Gari-Toussaint M; Marty P; Lanteri-Minet M; Barres P; Hoffman P; Onzon D; Richelme C; Cervera P; Mary C; Coussement A Bull Soc Pathol Exot Filiales; 1988; 81(5):869-76. PubMed ID: 3240570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]